Skip to main content
Clinical Trials/NCT04570891
NCT04570891
Recruiting
Not Applicable

Ultrasound-guided Fascia Iliaca Compartment Block for Proximal Femoral Osteotomy in Pediatric Patients: a Randomized Controlled Trial

Seoul National University Hospital1 site in 1 country36 target enrollmentDecember 15, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Orthopedic Disorder
Sponsor
Seoul National University Hospital
Enrollment
36
Locations
1
Primary Endpoint
total opioid consumption at 12 hours after the end of surgery
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This prospective randomized controlled trial aims to examine the effect of fascia iliaca compartment block on the postoperative pain and opioid consumption in pediatric patients (3y≤ age <18y) who will undergo orthopedics surgery (proximal femoral osteotomy).

Patients will be allocated to either the FICB(Fascia iliaca compartment block + IV PCA) group or the control group (no block + IV PCA). Fascia iliaca compartment block will be performed using 0.25% ropivacaine (1mL/kg, MAX 30mL) under ultrasound-guidance at the end of surgery.

The total opioid consumption at 12, and 24 hours after the surgery, and the pain score at 10 min after PACU admin, 1,6,24 hours after the surgery, the total dose of additional rescue analgesia (intravenous ketorolac or nalbuphine) at 12 and 24 hours after the surgery will be recorded.

Detailed Description

This prospective randomized controlled trial aims to examine the effect of fascia iliaca compartment block on postoperative pain and opioid consumption in pediatric patients (3y≤ age \<18y) who will undergo orthopedics surgery (proximal femoral osteotomy). Patients will be allocated to either the FICB(Fascia iliaca compartment block + IV PCA) group or the control group (no block + IV PCA). Fascia iliaca compartment block will be performed using 0.25% ropivacaine (1mL/kg, MAX 30mL) under ultrasound-guidance at the end of surgery. The total opioid consumption at 12, and 24 hours after the surgery, and the pain score at 10 min after PACU admin, 1,6,24 hours after the surgery, the total dose of additional rescue analgesia (intravenous ketorolac or nalbuphine) at 12 and 24 hours after the surgery will be recorded.

Registry
clinicaltrials.gov
Start Date
December 15, 2020
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jin-Tae Kim

Professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • 36 children aged between 3 and 18 years who undergo proximal femoral osteotomy

Exclusion Criteria

  • Complex surgery (other than proximal femoral osteotomy)
  • Allergy to opioid
  • Allergy to local anesthetics
  • Disease in heart, lung, kidney, and liver
  • Coagulation disorder
  • Disease in the central and peripheral nervous system
  • Unstable vital sign
  • Significant renal impairment (Creatinine\> 3.0 mg/dl)
  • Significant hepatic impairment (aspartate transaminase\> 120 unit/L, alanine aminotransferase\> 120 unit/L)

Outcomes

Primary Outcomes

total opioid consumption at 12 hours after the end of surgery

Time Frame: at 12 hours after the end of surgery

total opioid consumption at 12 hours after the end of surgery (IV Nalbuphine 1mg = IV Morphine 1mg = IV Fentanyl 10mcg (0.01mg) per kilogram of body weight.

Secondary Outcomes

  • total opioid consumption at 24 hours after the end of surgery(at 24 hours after the end of surgery)
  • Numeric rating scale(10 minutes after the PACU admin, 1hour, 6hours, and 24hours after the end of surgery.)
  • Total additional dose of ketorolac(at 12hours, and 24hours after the end of surgery.)
  • pupil constriction velocity (CV)(at 1 hour after the end of surgery)
  • Total additional dose of nalbuphine(at 12hours, and 24hours after the end of surgery.)
  • The incidence of side effects of ropivacaine(within 1 hour after the end of surgery)
  • Hospital stay(within 14 days after the end of surgery)
  • Neurological Pupil indexTM (NPi)(at 1 hour after the end of surgery)
  • Intact toe sensory at the second postoperative day (POD-2)(At the second postoperative day (POD-2))
  • Wong-Baker Faces Pain Rating Scale(at 10 minutes after the PACU admin, 1hour, 6hours, and 24hours after the end of surgery.)
  • The incidence of side effects of analgesic medications(within 24 hours after the end of surgery)
  • Normal capillary refill time (< 3 seconds) at the second postoperative day (POD-2)(At the second postoperative day (POD-2))
  • Extensor hallucis longus function (motor power of extension of the big toe: I-V) at the second postoperative day (POD-2)(At the second postoperative day (POD-2))

Study Sites (1)

Loading locations...

Similar Trials